The Back Space Continues Its Pilot Store Program in the Nashville market
BRENTWOOD, Tenn., Oct. 26, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”) today announces the completion of two additional locations of “The Back Space” retail healthcare centers specializing in chiropractic and spinal care services within Walmart stores. The Back Space will open two locations in the Nashville area this week to complement the original store opening in Murfreesboro, Tennessee.
“We are excited to continue our progress in opening additional ‘The Back Space’ locations. We have established a platform to deliver affordable spinal health and wellness services in a superior location,” commented Jeffrey Ervin, Chief Executive Officer of IMAC. “As we execute the ten-store pilot, we have identified several opportunities to improve on subsequent store openings which will reduce completion time and opening costs. Our well-established buildout process drives strong value and will be a benefit beyond the pilot program should we expand our store count.”
IMAC’s The Back Space offers walk-in and appointment-based spinal health and wellness services priced at $25 per treatment, with memberships available for $65 per month that are valid at any The Back Space location. More information can be found at www.back.co.
About IMAC Holdings, Inc.
IMAC Holdings owns and manages health and wellness centers that deliver sports medicine, orthopedic, and life science therapies for movement restricting diseases. IMAC is comprised of three business segments: outpatient medical centers, The Back Space, and a clinical research division. With treatments to address the aging population, IMAC Holdings owns or manages more than 15 outpatient medical clinics and has partnered with several active and former professional athletes, including Ozzie Smith, David Price, Mike Ditka, and Tony Delk to promote a minimally invasive approach to sports medicine. IMAC’s The Back Space retail spine health and wellness treatment centers deliver chiropractic care within Walmart locations. IMAC’s research division is currently conducting a Phase I clinical trial evaluating a mesenchymal stem cell therapy candidate for bradykinesia due to Parkinson’s disease. For more information visit www.imacholdings.com.
# # #
Safe Harbor Statement
This press release contains forward-looking statements. These forward-looking statements, and terms such as “anticipate,” “expect,” “believe,” “may,” “will,” “should” or other comparable terms, are based largely on IMAC's expectations and are subject to a number of risks and uncertainties, certain of which are beyond IMAC's control. Actual results could differ materially from these forward-looking statements as a result of, among other factors, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the skills and experience necessary to meet customers’ requirements, and its ability to protect its intellectual property. IMAC encourages you to review other factors that may affect its future results in its registration statement and in its other filings with the Securities and Exchange Commission. In light of these risks and uncertainties, there can be no assurance that the forward-looking information contained in this press release will in fact occur.
IMAC Press Contact:
Laura Fristoe
lfristoe@imacrc.com
Investor Relations:
Bret Shapiro
(516) 222-2560
brets@coreir.com
